Expanding Microbiome Therapeutics Strategies to Unlock European Market Opportunities & Overcoming Regulatory Hurdles
- Understanding critical US and EU market regulatory differences, including SoHO, to streamline market entry and avoid delays
- Navigating complexities of establishing European trial sites and novel regulatory pathways to de-risk therapeutic development investment effectively
- Outlining key strategies for successfully introducing an approved US drug into the European market to ensure effective penetration